John Crowley

2021

In 2021, John Crowley earned a total compensation of $1.6M as Chief Financial Officer at Fusion Pharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$159,691
Option Awards$979,441
Salary$440,713
Other$46,266
Total$1,626,112

Crowley received $979.4K in option awards, accounting for 60% of the total pay in 2021.

Crowley also received $159.7K in non-equity incentive plan, $440.7K in salary and $46.3K in other compensation.

Rankings

In 2021, John Crowley's compensation ranked 6,901st out of 12,415 executives tracked by ExecPay. In other words, Crowley earned more than 44.4% of executives.

ClassificationRankingPercentile
All
6,901
out of 12,415
44th
Division
Manufacturing
3,013
out of 5,505
45th
Major group
Chemicals And Allied Products
1,335
out of 2,375
44th
Industry group
Drugs
1,191
out of 2,096
43rd
Industry
Biological Products, Except Diagnostic Substances
282
out of 449
37th
Source: SEC filing on April 29, 2022.

Crowley's colleagues

We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2021.

2021

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2021

Eric Burak

Fusion Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like